**Core Concept**
Alpha-1-antitrypsin deficiency is a genetic disorder characterized by a deficiency of alpha-1-antitrypsin, a protease inhibitor produced in the liver. This deficiency can lead to the breakdown of lung tissue and other organs due to the unopposed action of elastase.

**Why the Correct Answer is Right**
Alpha-1-antitrypsin deficiency occurs due to mutations in the SERPINA1 gene, leading to the production of abnormal alpha-1-antitrypsin protein. This abnormal protein is retained in the liver cells, causing liver damage and impairing the production of normal alpha-1-antitrypsin. The deficiency of alpha-1-antitrypsin allows elastase to break down lung tissue, leading to chronic obstructive pulmonary disease (COPD) and other respiratory complications.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because alpha-1-antitrypsin deficiency is not primarily associated with hemophilia. Hemophilia is a bleeding disorder caused by deficiencies in clotting factors VIII or IX.
* **Option B:** This option is incorrect because cystic fibrosis is a different genetic disorder that affects the production of mucus and sweat. While both conditions can affect the lungs, they have distinct underlying mechanisms.
* **Option C:** This option is incorrect because Wilson's disease is a genetic disorder that affects copper metabolism, leading to liver and brain damage. It is not related to alpha-1-antitrypsin deficiency.

**Clinical Pearl / High-Yield Fact**
The most common mutation associated with alpha-1-antitrypsin deficiency is the PiZZ genotype, which accounts for about 80% of cases. This genotype is characterized by a combination of two mutations in the SERPINA1 gene.

**Correct Answer: D**.